Link to Asbestos Law Firm Los Angeles, Mesothelioma, Attorneys :http://vidnux.com/sq/8965/asbestos-law-firm-los-angeles-mesothelioma-attorneys.html
Forum Code :[url=http://vidnux.com/sq/8965/asbestos-law-firm-los-angeles-mesothelioma-attorneys.html][/url]
Description :http://kazanvideo.com Our attorneys know Asbestos-related legislation like no others. Our Asbestos l
]]>
some one sed that this riddel can make me rich on runescape
Malignant Mesothelioma is an uncommon form of cancer that occurs within the body at a section called the Mesothelium. Mesothelioma is known to be divided into the three main categories of Pleural Mesothelioma (70% of all Mesothelioma cases), Peritoneal Mesothelioma, and Pericardial Mesothelioma. Mesothelioma can affect workers working in Abestos mills, or just from being at a place constructed with traces of Abestos and other toxic substances within the materials used to construct the area someone is in.
Often times, those diagnosed with Mesothelioma have no clue that they have been exposed to the cancer causing substance usually until years later when the symptoms caused by Mesothelioma begin to emerge. Mesothelioma is a horrible case, but with the right type of Mesothelioma attorney/laywer, one can be entitled to anywhere from thousands to even millions of dollars in damages.
Mesothelioma treatment options can be discussed with your physician. the treatment options for mesothelioma is often on the pricey side, and that is where attorneys can help you get payment help from employers that may have caused your Mesothelioma. Through Mesothelioma lawsuits, many are able to be compensated a substantial amount, sometimes even in the millions.
Hint: the key to making 5-10m in 15 minutes lies in this page. getting to it might require you to look beyond what you see on this page. can a experriens runescape player helpy me out
]]>
By: Bello kamorudeenMesothelioma is most of the time caused by the inhalation of asbestos fibers. it is a cancer of the mesothelium. the mesothelium is the lining cover of the internal organs. this cancer typically affects the mesothelial lining of the lungs, heart and abdominal cavity.
When the lungs are affected, the cancer presents with symptoms of chest pain and difficulty in breathing, other symptoms like anaemia , weight loss show up at the latter stages of the disease.
The abdominal type of this cancer shows up with symptoms of weight loss, abdominal pain,abdominal swelling as a result of excessive fluid collection. Advanced cases of abdominal mesothelioma presents with symptoms of bowel obstruction, blood clotting abnormalities, anemia and fever.
When the tumor spreads to other parts of the body, there could be symptoms of pain and swelling of the face and neck. Difficulty in swallowing could also show up when the tumor spreads to the neck region.
Most victims inhaled these asbestos fibers while working for companies manufacturing and marketing asbestos fibers.These companies ,made huge profits at the expense of the health of their workers. if you have a history of exposure to asbestos and you have been diagnosed with mesothelioma you have a right to claim for compensation on various grounds.
Mesothelioma attorney in Houston will represent such victims of this rare and avoidable disease. He/she can get the victim and their families the compensation they deserve. this may not help cure the disease, but it may provide financi
al support to the affected.
The first lawsuit on mesothelioma was registered in 1966. since then, the mesothelioma lawyers have been able to get rightful compensations for many such unfortunate cases. In Houston or any place for that matter, finding a mesothelioma lawyer can be a tedious, long and tiresome process. You need to select a lawyer with whom you can have a good rapport. You need to meet a variety of lawyers before you can choose your right Houston mesothelioma lawyer. start your search in bar associations, Martindale-Hubbell Law directory, yellow pages and the Internet. then contact them by phone and explain your legal issue to them and ask how best they can handle the case. You need to seek clarifications regarding their initial consultation fee and the approximate cost to handle a mesothelioma lawsuit. then meet the prospective mesothelioma attorney in Houston, Texas to confirm for yourself his ability, knowledge and experience in handling such cases. After a brief introspection, you can make your choice regarding your lawyer.
It was Texas, in United States, where the first product liability cases against the manufacturer was recorded. Texas provides speedy trial settings for the mesothelioma victims and this ensures the chances that the victims will live to delight in their compensations. get a ‘no risk, free evaluation’ at your earliest convenience once you have chose on a Texas mesothelioma attorney.
Your lawyer will need to know your work history,names of co-workers and the type of asbestos brands and products used in the companies where you worked.
Be rest assured that filing for a mesothelioma case in Houston is the right thing to do as the laws in Texas are public friendly and your mesothelioma attorney has a very good chance of getting compensation for you.
Examples of mesothelioma lawyers in Houston Texas are: -Duboise lawfirm PLLC www.duboiselawfirm.com
-Michael R.Bilbery law offices,
PL -Cooney &Conway Lawfirm
-Find Legal connection www.Findlegalconnection.com
Bello kamorudeen is an health worker and author of several mesothelioma articles.for more information on mesothelioma lawyers go to http://www.mesothelioma.blogspot.com
]]>
Here is a question that i am curious to see how many people will give an honest answer. which do you prefer to be legalized Marijuana or Alcohol? Below are just a few facts about both…. (I did look up the facts that are posted on both marijuana and Alcohol I did not just make up these facts myself) I will try and post 10 facts each
Marijuana: #1 If Pot were legalized the prison industry would be hurt. They would no longer jail Pot smokers. it could free up space for violent criminals. #2 Pot is a sexual stimulant. #3 Pot is 100% natural nothing about it has man made chemicals in it. #4 there has never been a car accident death due to a stoned driver, just some slow drivers and may be some lost drivers . #5 Pot is used for medical use in MANY situations. #6 it is a myth that marijuana is a gate way drug. #7 Pot will cause some small term memory loss. #8 Pot will give you the Munchies, it could cause you to gain weight. #9 Marijuana smokers show dysregulated growth of epithelial cells in their lung tissue, which could lead to cancer; but, a recent case-controlled study found no positive associations between marijuana use and lung, upper respiratory, or upper digestive tract cancers. thus, the link between marijuana smoking and these cancers remains unsubstantiated at this time, but marijuana smokers have some of the same problems as cigarette smokers coughing, mucus, sore lungs, etc. #10 Marijuana make most people more relaxed. it relieves the clutter and tension after a hard days work or stress. it mellows you out and makes you more relaxed. it heightens the imagination and improves creativity. If you have a problem with anger, Pot is usually a good drug to reduce it, no one has ever died from smoking marijuana.
Alcohol: #1 In VERY SMALL amounts, alcohol can help a person feel more relaxed or less nervous. #2 Alcohol really blocks some of the messages trying to get to the brain. this alters a person’s perceptions, emotions, movement, vision, and hearing. #3 Depending on the person, intoxication can make someone very friendly and talkative or very aggressive and mad. #4 Reaction times are slowed dramatically — which is why people are told not to drink and drive. People who are intoxicated may reckon they’re moving properly when they’re not. They may act really out of character. #5 When large amounts of alcohol are consumed in a small period of time, alcohol poisoning can result. Alcohol poisoning is exactly what it sounds like — the body has become poisoned by large amounts of alcohol. Violent vomiting is usually the first symptom of alcohol poisoning. Extreme sleepiness, unconsciousness, difficulty breathing, dangerously low blood sugar, seizures, and even death may result. #6 one half of all drowning deaths among teen guys are related to alcohol use. Use of alcohol greatly increases the chance that a teen will be involved in a car crash, homicide, or suicide. #7 Teen drinkers are more likely to get fat or have health problems, too. one study by the University of Washington found that people who regularly had five or more drinks in a row starting at age 13 were much more likely to be overweight or have high blood pressure by age 24 than their non drinking peers. People who continue drinking heavily well into adulthood risk damaging their organs, such as the liver, heart, and brain. #8 the strongest medical evidence exists for the link between moderate drinking and a reduced risk of heart disease. #9 Alcohol has been linked to liver disease, cancers, heart hurt and strokes when consumed in larger amounts, and even small doses can lead to accidents, each year, approximately 5,000 young people under the age of 21 die as a result of underage drinking; this includes about 1,900 deaths from motor vehicle crashes, 1,600 as a result of homicides, 300 from suicide, as well as hundreds from other injuries such as falls, burns, and drownings. #10 Hangovers are another possible effect after large amounts of alcohol are consumed; a hangover consists of headache, nausea, thirst, dizziness, and fatigue.
In my opinion i reckon it’s safer to smoke a joint than it is to drink a beer, the most dangerous thing about marijuana is getting caught with it. you can google all this info your self before you answer i do not smoke or drink and i do not condone any of the above this is just my opinion on the subject, & I am just curious as to what every ones opinion is on the subject. I am just a homemaker and not any form of government at all or anything like that. also I looked every were for something good about drinking alcohol and found VERY limited info on it, so please don’t reckon this info posted is one sided for marijuana being good for you, I just found that using google as info finder it’s simpler to find good things about using pot than using beer.
]]>
Malignant Mesothelioma is an uncommon form of cancer that occurs within the body at a section called the Mesothelium. Mesothelioma is known to be divided into the three main categories of Pleural Mesothelioma (70% of all Mesothelioma cases), Peritoneal Mesothelioma, and Pericardial Mesothelioma. Mesothelioma can affect workers working in Abestos mills, or just from being at a place constructed with traces of Abestos and other toxic substances within the materials used to construct the area someone is in.
Often times, those diagnosed with Mesothelioma have no clue that they have been exposed to the cancer causing substance usually until years later when the symptoms caused by Mesothelioma start to emerge. Mesothelioma is a horrible case, but with the right type of Mesothelioma attorney/laywer, one can be entitled to anywhere from thousands to even millions of dollars in damages.
Mesothelioma treatment options can be discussed with your physician. the treatment options for mesothelioma is often on the pricey side, and that is where attorneys can help you get payment help from employers that may have caused your Mesothelioma.
The key to making 5-10m in 15 minutes lies in this page. getting to it might require you to look beyond what you see.
I found this on a runescape website that claims that you can make 5-10 mil in 15 minutes. it tells me that I can get filthy rich using this method. I know it is a well loved site, but I cant quite seem to find the secret in this. if anyone has found the secret PLEASE tell me what it is. I will be very thankful.thank you
runescape website help? please and than you! best answer=10 pts.?
]]>
I’m plotting on visiting an old, rundown building with several friends. I’m concerned about asbestos exposure, as the risk of cancer and other lung issues are prevalent upon being exposed. I don’t intend on touching/burning/destroying anything in the building, so as to avoid releasing potential asbestos into the air. Does anyone have any other suggestions as to how I may protect myself? Is it possible to be exposed simply by walking through an old building?
]]>
LOS ANGELES, Mar 31, 2010 (BUSINESS WIRE) –Response Genetics, inc. /quotes/comstock/15*!rgdx/quotes/nls/rgdx (RGDX 1.86, 0.00, 0.00%) , a company focused on the development and sale of molecular diagnostic tests for cancer, today announced consolidated financial results for the fourth quarter and year ended December 31, 2009, as well as an update on the Company’s ResponseDX(TM) sales activities.
“2009 was a very exciting year for Response Genetics as we saw significant growth and acceptance of our ResponseDX(TM) diagnostic tests. This trend has continued into 2010, with approximately 800 tests sold in March alone,” said Kathleen Danenberg, Response Genetics president and CEO. “We continue to do on our successful growth strategy; expanding our sales force, strengthening our balance sheet and establishing an international distribution network. for the coming year, we look forward to building on the momentum we have gained to further increase sales of our diagnostic tests and to advance our pipeline of products.”
Corporate Development Highlights
– ResponseDX(TM) Test Sales Continue to Ramp — Approximately 1,700 ResponseDX(TM) genetic tests were ordered in the fourth quarter of 2009. Revenue recorded from ResponseDX(TM) products increased 81 percent to $1.7 million in the fourth quarter of 2009, compared to $0.9 million in the third quarter of 2009. The Company continues to record revenues primarily on a cash basis from certain insurance providers until collection patterns are better determined. Cash collections continue to increase and we expect the cash associated with the majority of the tests processed during the fourth quarter of 2009 will be collected during the first quarter of 2010.
– Expanded Sales and Distribution — Response Genetics continued to expand its national sales force to meet demand for its Response DX(TM) tests, from three sales people in January 2009 to 15 currently. Company operations have seamlessly kept pace with the increased volume of ResponseDX(TM) tests to maintain the Company’s five-to-seven-day turnaround time. Response Genetics also established an international presence through a distribution partnership with Genetic Technologies, the largest private laboratory in Australia. ResponseDX(TM) tests are now available in Australia and certain Asian countries.
– Increased Reimbursement Due to Expanded ResponseDX(TM) Panels — With the addition of epidermal growth factor receptor (EGFR) mutational analysis, reimbursement of the Company’s ResponseDX: Lung(TM) panel increased from approximately $1,000 to $1,950, and ResponseDX: Colon(TM) test from approximately $950 to $1,100 with the addition of EGFR mutational analysis and BRAF mutational analysis. Approximately 50 percent of our ResponseDX(TM) revenue in 2009 was derived from our expanded ResponseDX: Lung(TM) panel. Response Genetics’ flexible technology allows the addition of new analytic capabilities as genes associated with therapeutic benefit to chemotherapy agents are identified.
– new ResponseDX(TM) Panel Launched Nationally — In September 2009, Response Genetics announced the nation-wide availability of its newest test panel, ResponseDX: Gastric(TM), a proprietary PCR-based diagnostic test that quantitatively analyzes three key genes — ERCC1, TS and HER2 — in tumors to help physicians make treatment decisions for patients with gastric cancer and gastroesophageal (GE) junction cancer. This new ResponseDX(TM) test is a product of the Company’s R&D pipeline and underscores its product development capabilities.
– $4 Million Private Placement — On March 5, 2010, Response Genetics entered into an agreement with funds managed by Lansdowne Partners Limited Partnership, Greenway Capital Partners and Paragon Associates whereby approximately $4 million was raised from a private placement of approximately 3 million newly issued shares of its common stock. Additionally, the Company announced two separate purchase agreements in 2009 with certain new and existing investors and raised a total of approximately $6 million. These funds are to be used by the Company to facilitate its sales goals and to expand its ResponseDX(TM) product offerings.
– Data Presented at ASCO and WCLC — At the annual meeting of the American Society of Clinical Oncology in Orlando, Response Genetics announced the results of studies identifying genes associated with positive chemotherapy outcome and tumor recurrence. and at the 13th World Conference on Lung Cancer in San Francisco, Response Genetics announced the results of separate analyses of KRAS gene mutations and TS and RRM1 gene expression in non-small cell lung cancer (NSCLC). These results, which were presented by Dr. David R. Gandara, University of California, Davis Cancer Center, and Dr. Philip Mack, University of California, Davis, provided insights into which patients are most likely to benefit from the commonly prescribed chemotherapies.
Financial Results for the Fourth Quarter ended December 31, 2009
Total revenue increased by 134 percent to $3.4 million for the fourth quarter ended December 31, 2009, compared to $1.4 million for the same period last year. Revenue from our ResponseDX(TM) genetic tests, which we started to sell in the third quarter of 2008, increased to $1.7 million for the fourth quarter ended December 31, 2009, compared to $0.2 million for the same period in 2008. Our pharmaceutical client revenue increased 38 percent to $1.7 million, compared to $1.3 million in the fourth quarter of 2008.
Cost of revenue for the fourth quarter ended December 31, 2009 was $1.8 million, compared with $0.9 million for the same period ended 2008. Research and development expenses were $0.6 million for the fourth quarter of 2009, compared with $0.4 million for the same period in the prior year. General and administrative expenses were $1.6 million for the fourth quarter ended December 31, 2009, compared with $1.8 million for the same period in 2008. Selling and marketing costs primarily related to the expansion of our ResponseDX(TM) tests totaled $1.1 million compared with $0.4 million for the same period in the prior year. Total operating expenses for the fourth quarter of 2009 were $5.1 million, compared with $4.9 million for the same period last year. Included in total operating expenses were costs related to the continued expansion of the Company’s ResponseDX(TM) tests, and its costs related to marketing and its sales force additions, which totaled $1.1 million for the fourth quarter. The increase in total operating expenses in the fourth quarter of 2009 were offset by lower costs of $1.4 million for the operations of our United Kingdom laboratory due to the closure of that facility in March 2009.
Response Genetics’ net loss for the fourth quarter ended December 31, 2009 was $1.7 million, or $0.11 per share, compared with a net loss of $3.4 million, or $0.33 per share, for the same period last year.
Financial Results for the Year ended December 31, 2009
Total revenue was $9.1 million for the year ended December 31, 2009, compared to $7.1 million for the year ended December 31, 2008, an increase of 28 percent. Revenue from our ResponseDX(TM) genetic tests totaled approximately $3.3 million. Our pharmaceutical client revenue decreased 16 percent to $5.8 million. as previously announced, this decrease was primarily due to a delay in the receipt of clinical samples from one of our major pharmaceutical clients, which the Company anticipates receiving in subsequent quarters through 2010.
Cost of revenue for the year ended December 31, 2009 was $5.7 million, compared with $4.0 million for the year ended December 31, 2008. Research and development expenses were $2.3 million for the year ended December 31, 2009, compared with $2.1 million for the year ended December 31, 2008. General and administrative expenses were $6.1 million for the year ended December 31, 2009, compared with $6.7 million for the year ended December 31, 2008. Selling and marketing costs primarily related to the expansion of our ResponseDX(TM) tests totaled $3.6 million for the year ended December 31, 2009 compared with $0.9 million for the same period in the prior year. Total costs for our now closed United Kingdom laboratory decreased to $0.7 million for the year ended December 31, 2009 compared to $3.4 million for the same period in 2008. Total operating expenses for the year ended December 31, 2009 were $18.5 million, compared with $17.0 million for the year ended December 31, 2008. The primary reasons for the increase in total operating expenses were costs related to the continued expansion of the Company’s ResponseDX(TM) tests and its sales force additions, which totaled $3.6 million for the year ended December 31, 2009. These expenses were offset by lower costs of 2.6 million for the operations of our United Kingdom lab due to the closure of that facility.
Response Genetics’ net loss for the twelve months ended December 31, 2009 was $9.3 million or $0.70 per share, compared with a net loss of $9.5 million, or $0.93 per share, for the same period last year.
Cash and Cash Equivalents
Cash and cash equivalents at December 31, 2009, were $7.1 million, compared to $9.5 million at December 31, 2008. as previously announced, Response Genetics completed a private placement of approximately 3.0 million newly issued common shares at a per-share price of $1.31. The Company received net proceeds of approximately $4.0 million from this private placement on March 5, 2010.
Reclassifications
Prior year amounts in the consolidated financial statements have been reclassified to conform to the current year presentation. Reclassified amounts had no impact on the Company’s net operating results.
About Response Genetics, inc.
Response Genetics, inc. (“RGI”) (the “Company”) /quotes/comstock/15*!rgdx/quotes/nls/rgdx (RGDX 1.86, 0.00, 0.00%) is engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies. RGI’s technologies enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin-embedded specimens. In addition to diagnostic testing services, RGI generates revenue from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. The Company was founded in 1999 and its principal headquarters are located in Los Angeles, California. for more information, please visit www.responsegenetics.com.
Forward-Looking Statement Notice
Except for the historical information contained herein, this press release and the statements of representatives of RGI related thereto contain or may contain, among other things, certain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995.
Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements with respect to the Company’s plans, objectives, projections, expectations and intentions, such as the ability of the Company to analyze cancer samples, the potential for using the results of this research to develop diagnostic tests for cancer, the usefulness of genetic information to tailor treatment to patients, the ability of the Company to expand its ResponseDX: Lung(TM) and ResponseDX: Colon(TM) test availability, the ability of the Company to continue to offer its ResponseDX Gastric(TM) tests, the ability of the Company to maintain or receive increased reimbursement of its tests, the ability of the Company to expand its sales force, the ability to continue to ramp the sales of ResponseDX and other statements identified by words such as “projects,” “may,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans” or similar expressions.
These statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties, including those detailed in the Company’s filings with the Securities and Exchange Commission. Actual results, including, without limitation, actual sales results, if any, or the application of funds, may differ from those set forth in the forward-looking statements. These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company’s control). The Company undertakes no obligation to publicly update forward-looking statements, whether because of new information, future events or otherwise, except as required by law.
RESPONSE GENETICS, INC.CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Three Months ended Year ended December 31, December 31, 2008 2009 2008 2009 (Unaudited) (Unaudited)Net revenue $ 1,441,362 $ 3,371,695 $ 7,124,771 $ 9,066,683Operating expenses:Cost of revenue 867,518 1,822,696 3,965,888 5,720,825Selling and marketing 352,623 1,113,693 878,706 3,621,030General and administrative 1,811,552 1,632,424 6,679,992 6,085,628UK operating expenses 1,431,685 18,617 3,371,513 752,901Research and development 433,044 559,080 2,088,832 2,293,303Total operating expenses 4,896,422 5,146,510 16,984,931 18,473,687Operating loss (3,455,060 ) (1,774,815 ) (9,860,160 ) (9,407,004 )Other income (expense):interest expense (848 ) (2,623 ) (3,875 ) (10,822 )Interest income 55,276 108 374,659 22,265Other (5,219 ) 49,718 (8,911 ) 49,718Loss before income taxes (3,405,851 ) (1,727,612 ) (9,498,287 ) (9,345,843 )Provision for income taxes (12,749 ) (4,788) (12,749 ) (4,788)Net loss $ (3,393,102 ) $ (1,722,824 ) $ (9,485,538 ) $ (9,341,055 )Unrealized loss on foreign currency translation – 10,642 – 46,350Total comprehensive loss $ (3,393,102 ) $ (1,712,182 ) $ (9,485,538 ) $ (9,294,705 )Net loss per share — basic and diluted $ (0.33 ) $ (0.11 ) $ (0.93 ) $ (0.70 )Weighted-average common shares — basic and diluted 10,239,276 15,297,183 10,239,276 13,276,095
SOURCE: Response Genetics, inc.
Trout Group Investor Relations: Peter Rahmer, 646-272-8526 or Fleishman-Hillard Media Relations: Barry Sudbeck, 415-318-4261
Copyright Business Wire 2010
Response Genetics, Inc. Reports Full Year 2009 and Fourth Quarter Financial …
]]>
Has anyone ever identified this insulation? Scientifically supported. I have and these insulations cause 48 diseases our political and scientific communities won’t discuss publicly. Why? I have the answer for CANCER! Remove fiberglass from America!
]]>
Initial response, not only from the patient, is often disbelief…”There must be a mistake! The test results must be incorrect!”, followed by questions on cures, care and ‘anything that you can do for me’ issues. Shock sets in.
Naturally the patient will be worried and unsure about his future. Though they may not show these reactions outwardly, they almost certainly will be thinking about them. Don’t assume that just because they appear ‘courageous’ on the outside that they are ‘taking it well’.
Some patients will find it simpler to talk with family and friends about their future than others do. Doing this may help the patient themselves come to terms with the diagnosis. Conversely, there are those that find it hard to talk about it to anyone. It that is the case then let them be. The patient has the right to be firm on the issue, in the small term anyway.
on the other side of the coin, friends and relatives may appear to be denying the diagnosis, changing the subject and playing down the patient’s worries and anxiety during conversations. perhaps its a coping mechanism for some people. nevertheless, the patient should confront them about these responses; they may be hurtful and it isn’t going to help the patient if he/she wishes to discuss the matter.
anger will almost certainly show itself in one way or another. often anger is aimed at those closest to the patient and the medical staff treating them. Patients shold not feel guilty about being mad and irritable. It is aimed at the illness and not others. It might be hard, but the patient could explain this to them, or show them relevant leaflets.
If the patient believes that your mesothelioma was caused by an employer and exposure to asbestos, they may feel resentment towards them. they could contact and or join a group that has been set up to deal with such issues. The patient may feel some relief through this strategy and there may even be some legal claim to be instigated.
Some patients may want to be left alone for a period to ’sort themselves out’ but friends and relatives may find this a hard period as they naturally want to help. The patient could reassure them that they will discuss the issues when they are ready.
Strong emotions are to be expected and dealt with. For both patient, friends and relatives.
Posted by General Health on Tuesday, September 05, 2006 at 6:57 PM | Permalink 
how much or how long would you need to be exposed to asbestos in order for it to harm you or in order for you to develop cancer?
]]>